article thumbnail

Cannabis Withdrawal Treatment Options Stimulated by Yale Study

Veriheal

Amid the hype of legalization in Connecticut, a cannabis addiction study conducted almost 40 miles away is delivering fascinating results. According to Yale University Professor of Psychiatry Cyril Desouza, where the study was carried out, approximately three out of 10 people are developing a cannabis use disorder.

article thumbnail

Medical Marijuana: An Alternative Treatment for Depression?

FloridaMarijuana.net

The study’s data showed that “Cannabis significantly reduced ratings of depression, anxiety, and stress.” Furthermore, researchers from the Washington State University found that cannabis with a low concentration of THC and high CBD concentration had the best results in reducing perceived symptoms of depression. appeared first on.

Treatment 100
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

States Have Made Over $15B From Cannabis Tax Revenue Despite Decline

Veriheal

A report was released by the Marijuana Policy Project (MPP) on May 1 on the combined sale of cannabis across the U.S. Since the state-legal, adult-use cannabis market began in 2014, a combined total of more than $15 billion has been generated in tax revenue. Cannabis Industry Has Greatly Boosted U.S.

article thumbnail

Is Cannabis a Good Treatment Option for Eating Disorders?

Greencamp

It takes just a few puffs of weed to get the munchies, but does this mean that medical cannabis works well for actual eating disorders? While the mainstream public is not convinced, some experts believe that cannabis can be used to help people get the better of their eating disorder. What are eating disorders?

article thumbnail

Beta-Caryophyllene: Terpene Powerhouse

Project CBD

Project CBD recently reported on studies indicating that cannabis terpenes — the compounds that give the plant its robust and distinctive smell — activate the CB1 cannabinoid receptor. Medical scientists are studying beta-caryophyllene as a treatment for non-alcoholic fatty liver disease, chronic pain, and substance abuse.

Terpenes 227
article thumbnail

Case Report Finds Cannabis Provides Symptom Relief in Those With Treatment-Resistant TBI

The Joint Blog

According to a new case report, the use of medical cannabis is associated with decreases in agitation and other symptoms of post-traumatic stress in a 38-year-old patient with an acquired traumatic brain injury (TBI). He reported no significant adverse side-effects from cannabis therapy.

article thumbnail

New Research Shows How Medicinal Cannabis Eases Cancer Pain and Reduces Opioid Dependence

Veriheal

But what if a safe and effective complementary plant-based treatment was widely available to alleviate cancer pain? A new 2023 study published in BMJ Supportive & Palliative Care suggests that cannabis could be the answer millions of cancer patients have been looking for. in cancer patients undergoing anticancer treatment, 50.7%